Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2005
05/17/2005US6894042 Azabicyclic compounds for the treatment of disease
05/17/2005US6894041 Oxazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes
05/17/2005US6894038 Administering an estriol 3,17-dipropionate or an estriol 3,17-dihexanoate, for treating multiple sclerosis
05/17/2005US6894036 4-dedimethylaminotetracycline derivatives
05/17/2005US6894035 Adhesive N,O-carboxymethylchitosan coatings which inhibit attachment of substrate-dependent cells and proteins
05/17/2005US6894034 Sebum production inhibitors
05/17/2005US6894033 Combination therapies using vitamin B12 and therapeutic agents for treatment of viral, proliferative and inflammatory diseases
05/17/2005US6894032 Or salt thereof
05/17/2005US6894030 Treatment of DNA viral infections
05/17/2005US6894026 Long-acting oxytocin analogues for the treatment and prevention of breast cancer and psychiatric disorders
05/17/2005US6894021 Method for identifying and using A2B adenosine receptor antagonists to mediate mammalian cell proliferation
05/17/2005US6893858 Human kcnq5 potassium channel, methods and compositions thereof
05/17/2005US6893844 DNA encoding a new human hepatoma derived growth factor and producing method thereof
05/17/2005US6893833 Use of NAD(P)H oxidase inhibitors to increase cellular uptake of glucose and in the treatment and/or prevention of diseases caused by insulin resistance or diseases related thereto, such as type II diabetes
05/17/2005US6893829 Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states
05/17/2005US6893821 Agents that modulate DNA-PK activity and methods of use thereof
05/17/2005US6893665 Tetracycline derivatives that are not removed from the gastro-intestinal tract via absorption, therefore having minimal systemic exposure and accompanying side effects in cancer therapy
05/17/2005US6893661 Hydrophobic ethylcellulose and hydrophillic hydroxyethyl-cellulose and/or hydroxypropyl methylcellulose; one a day tablets; consistent, reproducible delivery in presence of food; simple, inexpensive manufacturing
05/17/2005US6893660 Stable pharmaceutical compositions without a stabilizer
05/17/2005US6893659 Pharmaceutical composition for oral administration of a N-piperidino-3- pyrazolecarboxamide derivative, its salts and their solvates
05/17/2005US6893658 Active vitamin D3; light and heat stability; oily solution in shell comprised of gelatin, titanium oxide with yellow and/or red iron oxide
05/17/2005US6893656 Athletic patch
05/17/2005US6893655 Drug delivery
05/17/2005US6893654 Two-stage transmucosal medicine delivery system for symptom relief
05/17/2005US6893652 Comprises moxidectin, praziquantel, benzyl alcohol, ethanol, colloidal silicon dioxide, surfactant, and oil; veterinary medicine
05/17/2005US6893651 Synergistic combination of cyclic ketoenol with agonists or antagonists of nicotinic acetylcholine receptors; protecting plants
05/17/2005US6893642 Anticancer nutraceutical from spirulina
05/17/2005US6893641 Ganoderma lucidum spores for treatment of autoimmune diseases
05/17/2005US6893634 Without inflammatory or other immune response side effects; injection or implantation in tissue containing cancer growth; porous cellulose sulphate and polydimethyldiallylammonium membrane; breast and/or pancreatic tumors
05/17/2005US6893633 Methods and compositions for promoting the maturation of monocytes
05/17/2005US6893628 Aerosol formulations containing P134a and particulate medicament
05/17/2005US6892568 Noise detection system and method
05/17/2005CA2486752A1 Process for the removal of porogens from temperature sensitive macroreticular polymers using steam at reduced pressure
05/17/2005CA2402712C Compositions comprising blockers of l-dopa renal cell transfer for the treatment of parkinson's disease
05/17/2005CA2350061C New controlled release bead, a method of producing the same and multiple unit formulation comprising it
05/17/2005CA2347757C Method for producing (+)-exo-6-phenyl-3-azabicyclo-[3.2.0]heptanes
05/17/2005CA2335492C Pyrrolo[2,3-d]pyrimidine compounds
05/17/2005CA2306782C Isoquinolines as urokinase inhibitors
05/17/2005CA2305256C Mometasone furoate suspensions for nebulization
05/17/2005CA2304987C Inhibition of an fgf-binding protein using ribozymes
05/17/2005CA2301967C Azetidinone derivatives for the treatment of hcmv infections
05/17/2005CA2301548C Azetidinone derivatives for the treatment of hcmv infections
05/17/2005CA2301543C Azetidinone derivatives for the treatment of hcmv infections
05/17/2005CA2267945C Anticonvulsant derivatives useful in treating neuropathic pain
05/17/2005CA2267510C Process for manufacturing alpha-1l-adrenoceptor antagonists
05/17/2005CA2252907C Novel 2,3 disubstituted-4(3h)-quinazolinones
05/17/2005CA2174969C Short-acting dihydropyridines
05/17/2005CA2147502C Novel 7-(5-substituted cyclopentyl) and (5-substituted cyclopentenyl) heptyl alcohols, heptylamines and heptanoic acid amides, and method of lowering intraocular pressure in the eye of a mammal by administration of these novel compounds
05/17/2005CA2126327C Amidino derivatives and their use as nitric oxide synthase inhibitors
05/17/2005CA2125549C Tetrazole derivatives, their production and use
05/17/2005CA2117638C Adhesive bandages, wound dressings, sutures, drapes, orthodontic rubber bands, toothbrushes, and the like
05/17/2005CA2103845C 9-[(substituted glycyl)-amido]-6-demethyl-6-deoxytetracyclines
05/17/2005CA2057099C Bile acid derivatives, process for their preparation and use of these compounds as pharmaceuticals
05/12/2005WO2005043124A2 Chiral 1,8-diarylnaphthalenes, methods of making them, and their use as sensors
05/12/2005WO2005042773A1 Methods and compositions for identifying therapeutic compounds
05/12/2005WO2005042772A1 Methods and compositions for identifying therapeutic compounds
05/12/2005WO2005042727A2 Methods of organ regeneration
05/12/2005WO2005042718A2 Compositions and methods for treating, preventing, reversing and inhibiting pain
05/12/2005WO2005042710A1 Use of statin to kill ebv-transformed b cells
05/12/2005WO2005042697A2 Compounds, compositions and methods
05/12/2005WO2005042692A2 A method of inhibiting the expression of genes which mediate cellular cholesterol influx in animal cells and inhibiting the production of proteins resulting from the expression of such genes using cholesterol absorption inhibitors
05/12/2005WO2005042584A2 Sulfoalkyl ether-alkyl ether cyclodextrin derivatives
05/12/2005WO2005042583A1 Ec sod and cell transducing ec sod and use thereof
05/12/2005WO2005042570A1 Hcv ns3-ns4a protease resistance mutants
05/12/2005WO2005042555A1 Tyrosinase activity inhibitor and ameliorant for facial blood flow
05/12/2005WO2005042553A1 Method for the direct synthesis of oligorhamnosides, composition comprising oligorhamnosides and use thereof as a medicament
05/12/2005WO2005042552A2 Modulation of sglt2 expression
05/12/2005WO2005042542A1 2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis
05/12/2005WO2005042541A1 3-(4-aminophenyl) thienopyrimid-4-one derivatives as mch r1 antagonists for the treatment of obesity, diabetes, depression and anxiety
05/12/2005WO2005042539A1 Tocopherol-modified therapeutic drug compounds
05/12/2005WO2005042538A1 Spirofuropyridine aryl derivatives
05/12/2005WO2005042537A1 Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors
05/12/2005WO2005042534A2 A2b adenosine receptor antagonists
05/12/2005WO2005042533A2 2-cyanopyrrolidinecarboxamides as dipeptidyl peptidase-iv inhibitors
05/12/2005WO2005042531A1 Peptidomimetic compounds, stereoselective process for their preparation, their use as biologically active synthetic intermediates
05/12/2005WO2005042530A1 Rsv polymerase inhibitors
05/12/2005WO2005042528A1 Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same
05/12/2005WO2005042526A1 Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same
05/12/2005WO2005042525A1 Pyrimidin-4-yl-3, 4-thione compounds and their use in therapy
05/12/2005WO2005042524A1 Pyridine carboxamide and methods for inhibiting hiv integrase
05/12/2005WO2005042521A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
05/12/2005WO2005042518A2 Substituted heterocyclic compounds and methods of use
05/12/2005WO2005042517A2 Bipiperidinyl derivatives useful as inhibitors of chemokine receptors
05/12/2005WO2005042516A2 Ligands of melanocortin receptors and compositions and methods related thereto
05/12/2005WO2005042515A1 Novel crystalline forms of {2-[1-(3,5-bis-trifluoromethylbenzyl)-5-pyridin-4-yl-1h-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone
05/12/2005WO2005042514A2 Naphthalene-1,5-disulfonic acid salts of a substituted 4-amino-1-(pyridylmethyl)piperidine compound
05/12/2005WO2005042510A1 Tocopheryl polyethylene glycol succinate articles and process for preparing tpgs articles
05/12/2005WO2005042509A1 7-`(7-alkoxy)-chrom-3-en-6-yl!-heptatrienoic acid and 7-`(3­alkoxy)-5,6-dihydronaphthalen-2-yl!-heptatrienoic acid derivatives modulators
05/12/2005WO2005042508A1 PLANT-ORIGIN β3-ADRENOCEPTOR AGONIST AND USE OF THE SAME
05/12/2005WO2005042507A1 Bis {6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, (4e)-4-hexenoic acid} zinc salt
05/12/2005WO2005042504A1 Fluorinated resorufin compounds and their application in detecting hydrogen peroxide
05/12/2005WO2005042497A2 Benzimidazoles useful as modulators of ion channels
05/12/2005WO2005042491A1 Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
05/12/2005WO2005042489A1 N-substituted benzene sulfonamides
05/12/2005WO2005042487A1 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease
05/12/2005WO2005042486A1 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease
05/12/2005WO2005042483A1 [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-((1-methylethyl) -3-phenyl-4-[(phenylamino) carbonyl]- 1h-pyrrole-1-heptanoic acid iron salt
05/12/2005WO2005042482A1 Vitamin d3 lactam derivative
05/12/2005WO2005042481A2 COMPOUNDS AND RELATED METHODS FOR MUTANT p53 REACTIVATION
05/12/2005WO2005042478A2 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
1 ... 4690 4691 4692 4693 4694 4695 4696 4697 4698 4699 4700 4701 4702 4703 4704 4705 4706 4707 4708 4709 4710 ... 7860